Navigation Links
BioMedical Life Systems, Inc. Launches New FDA Cleared Non-Prescription TENS Device

Vista CA (PRWEB) June 06, 2013

BioMedical Life Systems, Inc. ( makers of Leading Prescription Pain Relief devices for Medical Professionals, serving the durable medical equipment (DME) dealer and distributor market - for over 30 years, has received FDA clearance to market its newest innovation, the REBOUND™ Health TENS device, without a prescription. This launch catapults the company into the newly emerging medical retail environment and enables this time tested technology to now be available directly to the public.

The REBOUND™ Health is a TENS unit (Transcutaneous Electrical Nerve Stimulator) pain relief device that works “through the skin”, transmitting through electrode pads that are attached to the outside of the skin emitting a “tingling sensation” to help manage pain without the use of drugs. Scientific research suggests that the REBOUND™ Health TENS unit (electro-therapy) can be used to relieve chronic or acute pain by blocking the pain signals and triggering a release of endorphins, which provide natural pain relief.

“This is an amazing development in the effort to provide pain relief alternatives without the use of drugs that may potentially have harmful side effects. BioMedical Life Systems, Inc. has always had the philosophy that the option of drug-free pain relief should be available to everyone. Prior to this FDA clearance, the TENS units were only available with a written prescription. Now, TENS unit technology is finally available over-the-counter. We are pleased to see that the government is recognizing this need for change, and taking the necessary steps to enable wider access to the technology”- Mariah Griffith, Vice President of Sales and Marketing for Biomedical Life Systems, Inc.

The REBOUND™ Health ( TENS unit is a compact, extremely durable, portable unit measuring 4.9" x 1.4" x .65”, weighs only 1.3 oz. The TENS device is packaged for retail sale with all necessary accessories. The REBOUND™ TENS unit is Effective and Safe-to-Use for Pain Relief from: Hip, Low Back and Mid-Back Pain, Elbow and Wrist Pain, Shoulder and Arm Pain, Knee Pain, Ankle Pain, Joint and Muscle Pains. Simply Surround Your Pain, Power Up and Go! ™.

For further information:
BioMedical Life Systems, Inc.
PO Box 1360, Vista, CA 92085-1360.
E-mail: information(at)bmls(dot)com
Tel: (Toll Free) 1-800-726-8367
Fax: 760-727-4220

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Ondine Biomedical CEO Carolyn Cross Appointed Treasurer of International Photodynamic Association
2. Arteriocyte announces Launch of Compass Biomedical
3. Regenesis Biomedical Names Scott Brooks Chief Executive Officer
4. Premier Biomedical CEO Interviewed by The Wall Street Transcript
5. ICMs New Blue Gene Supercomputer Supports The Largest Biomedical Research Initiative In Poland
6. New Opportunity: The Biomedical Innovations of Tomorrow - Research Report on PhotoMedex, Axiall Corp, Varian Medical Systems, Volcano Corporation and Navidea Biopharmaceuticals
7. Lupus Research Institute Requests Strengthened NIH Funding for Biomedical Research in Debilitating Diseases like Lupus
8. Fourth Annual Bay Area Biomedical Device Conference: March 27th, 2013 at San Jose State University
9. Foundation for the NIH Announces Lurie Prize Recognizing Outstanding Achievement by a Young Biomedical Scientist
10. ABIA Hires Biomedical Executive, Serial Entrepreneur as Chief Operating Officer
11. Market Outlook: The Future of Biomedical Materials
Post Your Comments:
(Date:11/25/2015)...  Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) announced ... of Neurocrine Biosciences, will be presenting at the 27th ... York . .   ... minutes prior to the presentation to download or install ... be available on the website approximately one hour after ...
(Date:11/25/2015)... ... November 25, 2015 , ... Jessica Richman and Zachary ... in their initial angel funding process. Now, they are paying it forward to ... early stage investments in the microbiome space. In this, they join other ...
(Date:11/24/2015)... , Nov. 24, 2015 /CNW/ - iCo Therapeutics ("iCo" ... reported financial results for the quarter ended September ... in Canadian dollars and presented under International Financial ... States ," said Andrew Rae , ... regarding iCo-008 are not only value enriching for ...
(Date:11/24/2015)... , November 24, 2015 ... market research report "Oligonucleotide Synthesis Market by Product & ... Gene Synthesis, Diagnostic, DNA, RNAi), End-User (Research, Pharmaceutical & ... by MarketsandMarkets, the market is expected to reach USD ... 2015, at a CAGR of 10.1% during the forecast ...
Breaking Biology Technology:
(Date:11/11/2015)... --  MedNet Solutions , an innovative SaaS-based eClinical technology company ... to announce that it will be a Sponsor of the ... be held November 17-19 in Hamburg , ... iMedNet , MedNet,s easy-to-use, proven and affordable ... been able to deliver time and cost savings of up ...
(Date:11/4/2015)... New York , November 4, 2015 ... to a new market report published by Transparency Market ... Share, Growth, Trends and Forecast 2015 - 2022", the global ... of US$ 30.3 bn by 2022. The market is ... the forecast period from 2015 to 2022. Rising security ...
(Date:10/29/2015)... Oct. 29, 2015  Rubicon Genomics, Inc., today ... distribution of its DNA library preparation products, including ... new ThruPLEX Plasma-seq kit. ThruPLEX Plasma-seq has been ... of NGS libraries for liquid biopsies--the analysis of ... prognostic applications in cancer and other conditions. Eurofins ...
Breaking Biology News(10 mins):